sec filing
AS
NASDAQ · ASBP
Aspire Biopharma Holdings, Inc.
Healthcare · Biotechnology
$8.58
Up+$0.38 (+4.63%)
Updated Sep 17, 2026, 7:40 AM
SID Score
4.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 4.81M
- P/E ratio
- -9.59
- Dividend yield
- 0.00%
- 52-week range
- $0.16 – $18.76
- Volume
- 14.9K
- Avg. volume
- 1.05M
Price performance
ASBP price history
1M range · 20 trading sessions · Daily adjusted prices
ASBP closed at $8.58 after 20 trading sessions, up 8.61% for the selected period.
- Last close
- $8.58
- Period change
- +8.61%
- Period low
- $7.81
- Period high
- $9.25
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | $8.05 | $8.61 | $8.05 | $8.58 | 14.9K |
| Sep 15, 2026 | $8.69 | $8.76 | $7.99 | $8.20 | 48.33K |
| Sep 14, 2026 | $8.88 | $9.04 | $8.6646 | $8.86 | 16K |
| Sep 11, 2026 | $9.24 | $9.3783 | $9.06 | $9.06 | 26.84K |
| Sep 10, 2026 | $8.21 | $9.25 | $8.21 | $9.12 | 35.5K |
| Sep 9, 2026 | $8.70 | $9.00 | $7.80 | $8.61 | 118.03K |
| Sep 8, 2026 | $8.89 | $9.0397 | $8.82 | $8.85 | 8.87K |
| Sep 4, 2026 | $9.25 | $9.50 | $8.80 | $8.87 | 43.09K |
| Sep 3, 2026 | $9.13 | $9.4097 | $9.10 | $9.25 | 27.06K |
| Sep 2, 2026 | $8.86 | $9.34 | $8.78 | $9.205 | 35.26K |
| Sep 1, 2026 | $8.735 | $9.25 | $8.735 | $8.91 | 59.69K |
| Aug 31, 2026 | $8.49 | $9.00 | $8.49 | $8.98 | 26.13K |
| Aug 28, 2026 | $8.30 | $8.70 | $8.07 | $8.51 | 21.48K |
| Aug 27, 2026 | $8.33 | $8.65 | $8.25 | $8.26 | 8.21K |
| Aug 26, 2026 | $8.27 | $8.555 | $8.27 | $8.33 | 11.42K |
| Aug 25, 2026 | $7.60 | $8.80 | $7.60 | $8.27 | 28.88K |
| Aug 24, 2026 | $7.79 | $8.21 | $7.79 | $7.81 | 43.75K |
| Aug 21, 2026 | $8.01 | $8.20 | $7.9023 | $7.97 | 31.92K |
| Aug 20, 2026 | $7.99 | $8.1532 | $7.77 | $7.82 | 15.98K |
| Aug 19, 2026 | $7.96 | $8.18 | $7.6176 | $7.90 | 44.67K |
Latest ASBP news
The latest Smart Investors Daily articles mentioning ASBP.
Stock researchResearch & News · SEC Filings
Loading stock research…

